Published in Hepatitis Weekly, March 5th, 2001
The prospect of being able to perform this feat in humans would be a huge leap forward in treating patients with various liver ailments.
"A strategy for hepatocyte transplantation was recently developed whereby massive replacement of the recipient liver is achieved after a combined treatment with retrorsine, a pyrrolizidine alkaloid, and partial hepatectomy," S. Laconi and colleages explained.
To deduce whether repopulation could occur in the absence of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.